Tesla (NASDAQ: TSLA) and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving…
Read More »Wegovy
The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…
Read More »With the obesity drug market poised for exponential future growth, here’s the skinny on the top obesity and weight-loss stocks…
Read More »